Nanofibrous Platforms for Advanced Wound Therapeutics: Mechanisms, Materials, and Clinical Horizons

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

• Level A · Stronger Clinical Evidence
• Level B · Emerging clinical evidence with positive signals
• Level C · Early human research exploring benefits
• Level D · Scientific groundwork from lab and animal studies
• Emerging · Emerging topic under active research

Abstract (original English)

Nanofibrous dressings have emerged as a transformative solution for acute and chronic wound management. This review evaluates recent advancements in wound therapeutics utilizing nanofiber platforms incorporating various bioactive agents. A comprehensive overview of the wound healing process across distinct physiological phases is provided, alongside a discussion of nanofiber fabrication methodologies and their underlying mechanisms. Particular emphasis is placed on the constituent materials and their inherent biofunctionality, specifically regarding how cellular interactions with these substrates enhance wound healing outcomes. Furthermore, we examine the clinical utility of these scaffolds in achieving hemostasis, modulating inflammation, preventing infection, and promoting angiogenesis. The review concludes by highlighting the cost-effectiveness and tunable architecture of nanofibers, underscoring their potential as the next generation of efficacious wound care systems.

Evidence level

Evidence from laboratory and animal studies provides groundwork for understanding mechanisms and potential before human studies continue.

Browse all related research

Filter the research library by this study's title keywords, author, or publication year.